Laboratory tests in mice have shown promise
A potential new antidepressant and antianxiety treatment with a unique mechanism of action has been developed by scientists at the University of Bath.
The compound has shown significant potential after studies in mice. The research is published in the British Journal of Pharmacology.
Dr Sarah Bailey and Professor Steve Husbands with their research team
Around one in six adults will experience depression in their lifetimes. New drugs to treat depression in particular are needed because many existing antidepressants don’t work in up to 50% of patients. This new University of Bath compound, known as BU10119, works in a different way to the most common antidepressant drugs; selective serotonin reuptake inhibitors (SSRIs), and may therefore offer a new potential treatment for those in whom SSRIs don’t work.
Unlike SSRIs which target the serotonin system in the brain, BU10119 works by blocking receptors called kappa opioid receptors. Blocking these receptors has been shown to have anti-depressant like effects in mice.
In a series of laboratory trials, mice given BU10119 demonstrated behaviours consistent with providing antidepressant–like effects.
Dr Sarah Bailey, Senior Lecturer in the Department of Pharmacy & Pharmacology at the University of Bath, said: “I’m really quite excited by the potential of this compound. Developing new medicines is why I got into pharmacology and, in 20 years of research, this is the closest I have come to a new compound that might translate towards the clinic. It’s promising, but that said, we are still at an early stage, these experiments are in mice and further research is still required for example to establish safety.
“SSRIs can work very well for some patients, but we know they don’t work for everyone which is one reason why developing new antidepressant and antianxiety drugs could be really beneficial.”
The researchers were inspired to develop the compound after previous University of Bath research showed that a combination of two existing drugs, buprenorphine and naltrexone, had potential as an antidepressant. BU10119 combines the effects of this combination in one drug.
Professor Stephen Husbands, Head of Medicinal Chemistry at the University of Bath added: “This research builds on our previous work which showed that combining buprenorphine and naltrexone can give antidepressant effects in mice. By combining the effects of both drugs in one molecule we hope that a safe and effective drug will eventually be the outcome. BU10119 is part of a series of compounds now licensed to, and under development with, Orexigen Therapeutics.”
The study was funded a by a National Institute on Drug Abuse grant and a PhD scholarship from the Government of Saudi Arabia.
The University of Bath has signed the Concordat on Openness on Animal Research. The University is committed to enhancing our communications with the media and public about our research using animals. Find out more: http://www.bath.ac.uk/collections/animal-research/
Learn more: New drug shows potential as a different kind of antidepressant in mouse trials
The Latest on: Depression and anxiety
- 9 celebrity tips for dealing with stress and anxietyon August 1, 2022 at 8:49 am
Not only do stress and anxiety make us feel discouraged and unmotivated, but they can also lead to serious health problems. According to the American Institute of Stress, effects can include increased ...
- Digital therapeutic improves symptoms of insomnia, anxiety, depression for 6 monthson August 1, 2022 at 7:08 am
Data from a real-world study revealed that treatment with prescription digital therapeutic Somryst achieved reductions in symptoms of insomnia, anxiety and depression, per a late-breaking poster at ...
- University of Alabama at Birmingham: Study shows pandemic increased depression and anxiety in dental health care workerson August 1, 2022 at 5:19 am
Research published in the Journal of the American Dental Association involving faculty from the School of Dentistry found that dental health care providers reported anxiety and depression symptoms ...
- ‘You can get out of it’: Boxer Danny Garcia opens up on battling ‘depression and anxiety’on August 1, 2022 at 4:06 am
Danny Garcia delivered a powerful message on mental health after defeating Jose Benavidez Jr on Saturday, opening up on his ‘battle’ with ‘depression and anxiety’. Garcia was returning to the ring ...
- Dementia caregivers report less anxiety, depression during pandemicon July 31, 2022 at 12:08 pm
Individuals caring for those with dementia “surprisingly” experienced reduced anxiety and depression during the COVID-19 related lockdowns, according to a presentation at the Alzheimer’s Association ...
- Scientists Find Strong Magnetic Fields Can Relieve Anxiety and Depressionon July 31, 2022 at 11:45 am
Scientists recently conducted a series of studies to test the biosafety and neurobehavioral effects of 33.0 Tesla high static magnetic fields (SMF) using the self-designed biological research platform ...
- 9 Tools to Prevent Anxiety and Depressionon July 29, 2022 at 10:05 am
The percentage of adults with recent symptoms of anxiety or depression increased from 36.4 to 41.5 percent in the U.S. between August 2020 and February 2021, with the largest increases among adults 18 ...
- Study shows pandemic increased depression and anxiety in dental health care workerson July 28, 2022 at 3:07 pm
The first known U.S. study evaluates the mental health of practicing dentists and dental hygienists during the COVID-19 pandemic.
- New study suggests B6 supplements could help to relieve symptoms of anxiety and depressionon July 28, 2022 at 9:04 am
However, a new study, published in the journal Human Psychopharmacology: Clinical and Experimental, points to B6 supplements as a possible method for helping with anxiety and depression symptom ...
- How do psychedelics combat anxiety and depression? MGH researchers are determined to find out.on July 25, 2022 at 6:15 pm
Cycles of negative thoughts are a major problem for those battling mental illness. Could a compound found in "magic mushrooms" ease their pain?
via Google News and Bing News
